ISPC iSpecimen Inc. Price Chart

The price action of iSpecimen Inc. (ISPC) securities demonstrates a trend at the current 0.71 level, which correlates with scientific research funding volumes. iSpecimen Inc. (ISPC) generates revenue by mediating between medical centers and scientists via a digital biospecimen marketplace. Supply reliability is ensured by strict adherence to temperature controls during tissue transport. Business stability is supported by consistent demand from laboratories and the loyalty of partner clinics.

Quote Chart: iSpecimen Inc. (ISPC) for 07/04/2022 - 11/12/2026

Analytical breakdowns and data insights for company iSpecimen Corp (ISPC)

- stock quotes and analyst forecast:

Stock Price iSpecimen Inc.|ISPC - Analyst Median Target

- market capitalization data:

Market Value iSpecimen Inc|ISPC - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share iSpecimen|ISPC - Net Asset Value|Market Capitalization to Book Value Ratio ispecimen.com|ISPC - Cumulative Company Assets

- debt and liquidity details:

- company profitability and valuation multiples indicators:

ISPC - Company Net Income|Projected Future Earnings iSpecimen Inc.|ISPC - Price to Earnings Multiple|Forward P/E Multiple iSpecimen Inc.|ISPC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iSpecimen Inc|ISPC - Operating income before deduction of amortization|Earnings per share for the last twelve months iSpecimen|ISPC - Earnings per one share for the last 12 months|Quarterly EPS earnings growth ispecimen.com|ISPC - Earnings per share growth rate in current year|Earnings growth forecast for next year iSpecimen Inc.

Summary company analysis:iSpecimen ISPC

The price reflects the dynamics of the shares' market value, where a consistent rise in asset quotes signals a recovery in investor confidence and the overcoming of previous downturns. This indicator discounts the resilience of iSpecimen Inc. (ISPC), whose operations within the legal frameworks of the US and EU eliminate sanctions risks, providing a stable foundation for a long-term price trend.

Direct competitors